期刊文献+

肝癌发生过程中的差异基因表达 被引量:9

Expression of differential genes during hepatocarcinogenesis
下载PDF
导出
摘要 目的:应用寡核苷酸芯片研究正常肝脏、慢性乙型肝炎、肝硬化及肝癌的基因表达谱,筛选肝癌相关基因.方法:分别对正常肝组织及肝炎、肝硬化和肝癌组织进行总RNA抽提并纯化,反转录得到cDNA,生物素标记cRNA探针,分别与含有19378个已知基因的寡核苷酸芯片进行杂交,Gene Scanner 3000激光系统扫描,GenePix Pro3.0分析软件读取处理杂交信号.结果:在慢性乙型肝炎、肝硬化及肝癌组织中,筛选出共同差异表达基因81个,其中持续上调表达基因53个,持续下调表达基因数28个.结论:寡核苷酸基因表达谱芯片能够快速筛选出肝癌相关基因,有多种基因共同参与肝癌发生的整个过程. AIM: To investigate the gene expression profiles in tissues of normal human liver, chronic hepatitis B, cirrhosis and hepatocellular carcinoma (HCC) by oligonucletide chip, and to screen HCC-related genes. METHODS: The total RNA was extracted and reverse transcribed into double-strand cDNA, and then transcribed into biotin-labled cRNA target probes. The probes were hybridized with oligonucleotide chip containing 19378 genes respectively. Subsequently, the signal images were scanned by gene Scanner 3000 and analyzed with GenePix Pro 3.0 software. RESULTS: Eighty-one genes differentially expressed among tissues of chronic hepatitis B, cirrhosis and HCC were screened out in the gene expression profiles. Of the 81 genes, 53 genes were consistently up-regulated, while 28 genes were consistently down-regulated CONCLUSION: The oligonucleotide chip of gene expression profile is powerful for screening HCC-related genes. Our results indicate that multiple genes take part in the carcinogenesis of HCC.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第22期2537-2541,共5页 World Chinese Journal of Digestology
基金 河南省医学科技创新基金资助项目 No.20050080~~
关键词 寡核苷酸芯片 基因表达谱 肝细胞癌 Oligonucleotide chip Gene expression profile Hepatocellular carcinoma
  • 相关文献

参考文献12

  • 1Kao JH, Chen DS. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int 2005; 25:696-703 被引量:1
  • 2Dudda-Subramanya R, Lucchese G, Kanduc D,Sinha AA. Clinical applications of DNA microarray analysis. J Exp Ther Oncol 2003; 3:297-304 被引量:1
  • 3Munz M, Zeidler R, Gires O. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett 2005; 225:151-157 被引量:1
  • 4Liljefors M, Nilsson B, Fagerberg J, Ragnhammar P, Mellstedt H, Frodin JE. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma. Int J Onco12005: 26:1581-1589 被引量:1
  • 5Lim SC, Oh SH. The role of CD24 in various human epithelial neoplasias. Pathol Res Pract 2005; 201: 479-486 被引量:1
  • 6Sagiv E, Memeo L, Karin A, Kazanov D, Jacob- Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131:630-639 被引量:1
  • 7Son HJ, Sohn TS, Song SY, Lee JH, Rhee JC. Maspin expression in human gastric adenocarcinoma. Pathol Int 2002; 52:508-513 被引量:1
  • 8Chen EI, Yates JR. Maspin and tumor metastasis. IUBMB Life 2006; 58:25-29 被引量:1
  • 9de Bruin WC, Wagenmans MJ, Board PG, Peters WH. Expression of glutathione S-transferase theta class isoenzymes in human colorectal and gastric cancers. Carcinogenesis 1999; 20:1453-1457 被引量:1
  • 10Geylan-Su YS, Isgor B, Coban T, Kapucuoglu N, Aydintug S, Iscan M, Iscan M, Guray T. Comparison of NAT1, NAT2 and GSTr2-2 activities in normal and neoplastic human breast tissues. Neoplasma 2006, 53:73-78 被引量:1

同被引文献44

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部